$271.59
-0.71%The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
Quality against peers; 50 is the peer median.
PM peer median: the typical company the value is compared with. The /100 is its score against those peers.